U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Webinar: Framework for FDA’s Real-World Evidence Program – Mar 15, 2019
  1. Drugs

Webinar: Framework for FDA’s Real-World Evidence Program – Mar 15, 2019

Slides

Framework for FDA’s Real World Evidence Program

About this Webinar

As part of the 21st Century Cures Act, the FDA released a framework for our Real-World Evidence (RWE) program.  The goal for this webinar is to inform the public of FDA’s effort to understand the utility of real-world data (RWD) to generate evidence for regulatory decisions.

Learning Objectives

At the end of this webinar, participants will be able to:

  1. Describe the main elements of FDA’s real-world evidence (RWE) Program.
  2. List FDA considerations for evaluating the use of real-world data to generate RWE for regulatory decisions.
  3. Explain program items the Agency plans to address in the RWE Program.
  4. Describe at least one demonstration project that will help inform the use of RWD and RWE.

Who Should Attend

Stakeholders working on RWD and RWE to include:

  • Regulatory affairs professionals
  • Academia
  • Clinical research organizations
  • RWD Curators

FDA Speaker

Jacqueline Corrigan-Curay, J.D., M.D.
Director
Office of Medical Policy
Center for Drug Evaluation and Research
FDA

Back to Top